Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction

The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper auth...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Thomas W., Aichinger, Josef, Huber, Kurt, Speidl, Walter S., Watzinger, Norbert, Zweiker, Robert, Alber, Hannes F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916195/
https://www.ncbi.nlm.nih.gov/pubmed/27278134
http://dx.doi.org/10.1007/s00508-016-1016-7
_version_ 1782438786233270272
author Weiss, Thomas W.
Aichinger, Josef
Huber, Kurt
Speidl, Walter S.
Watzinger, Norbert
Zweiker, Robert
Alber, Hannes F.
author_facet Weiss, Thomas W.
Aichinger, Josef
Huber, Kurt
Speidl, Walter S.
Watzinger, Norbert
Zweiker, Robert
Alber, Hannes F.
author_sort Weiss, Thomas W.
collection PubMed
description The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper authored by Austrian experts is to outline the current evidence and provide an overview of recent studies. It is also intended to serve as a practical guide to identify those patients who may benefit from prolonged DAPT.
format Online
Article
Text
id pubmed-4916195
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-49161952016-07-06 Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction Weiss, Thomas W. Aichinger, Josef Huber, Kurt Speidl, Walter S. Watzinger, Norbert Zweiker, Robert Alber, Hannes F. Wien Klin Wochenschr Review Article The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper authored by Austrian experts is to outline the current evidence and provide an overview of recent studies. It is also intended to serve as a practical guide to identify those patients who may benefit from prolonged DAPT. Springer Vienna 2016-06-09 2016 /pmc/articles/PMC4916195/ /pubmed/27278134 http://dx.doi.org/10.1007/s00508-016-1016-7 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review Article
Weiss, Thomas W.
Aichinger, Josef
Huber, Kurt
Speidl, Walter S.
Watzinger, Norbert
Zweiker, Robert
Alber, Hannes F.
Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
title Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
title_full Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
title_fullStr Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
title_full_unstemmed Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
title_short Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
title_sort expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916195/
https://www.ncbi.nlm.nih.gov/pubmed/27278134
http://dx.doi.org/10.1007/s00508-016-1016-7
work_keys_str_mv AT weissthomasw expertpositionpaperonprolongeddualantiplatelettherapyinsecondarypreventionfollowingmyocardialinfarction
AT aichingerjosef expertpositionpaperonprolongeddualantiplatelettherapyinsecondarypreventionfollowingmyocardialinfarction
AT huberkurt expertpositionpaperonprolongeddualantiplatelettherapyinsecondarypreventionfollowingmyocardialinfarction
AT speidlwalters expertpositionpaperonprolongeddualantiplatelettherapyinsecondarypreventionfollowingmyocardialinfarction
AT watzingernorbert expertpositionpaperonprolongeddualantiplatelettherapyinsecondarypreventionfollowingmyocardialinfarction
AT zweikerrobert expertpositionpaperonprolongeddualantiplatelettherapyinsecondarypreventionfollowingmyocardialinfarction
AT alberhannesf expertpositionpaperonprolongeddualantiplatelettherapyinsecondarypreventionfollowingmyocardialinfarction

Ejemplares similares